🇺🇸 FDA
Patent

US 7622549

Human telomerase reverse transcriptase polypeptides

granted A61KA61K2039/55505A61K2039/55511

Quick answer

US patent 7622549 (Human telomerase reverse transcriptase polypeptides) held by The Regents of the University of Colorado expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/55505, A61K2039/55511, A61K2039/55516, A61K2039/55544